Enlivex Therapeutics (ENLV) Stock Chart & Stock Price History → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free ENLV Stock Alerts $1.47 +0.11 (+8.09%) (As of 04:00 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestTrends Enlivex Therapeutics Stock Price Performance5 Day Performance+12.21%1 Month Performance-9.26%3 Month Performance-54.21%6 Month Performance-18.33%Year-To-Date Performance-45.56%1 Year Performance-44.42% Receive ENLV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Enlivex Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Colonial MetalsThe Hidden Anchor Investment of the Elite RevealedThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. ENLV Stock Chart for Monday, June, 3, 2024 ENLV Chart by TradingView Enlivex Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$1.35$1.36+0.75%$1.36$1.317,229 shs$25.30 million05/30/2024$1.31$1.35+3.05%$1.40$1.3120,225 shs$25.11 million05/29/2024$1.38$1.31-5.07%$1.36$1.3141,924 shs$24.37 million05/28/2024$1.40$1.38-1.43%$1.50$1.31266,281 shs$25.67 million05/27/2024$1.40$1.40$1.40$1.3025,500 shs$26.04 million05/24/2024$1.36$1.40+2.94%$1.40$1.3025,517 shs$26.04 million Get the Latest News and Ratings for ENLV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enlivex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$1.44$1.36-5.56%$1.40$1.3616,990 shs$25.30 million05/22/2024$1.49$1.44-3.36%$1.47$1.3356,189 shs$26.78 million05/21/2024$1.42$1.49+4.93%$1.49$1.4133,815 shs$27.71 million05/20/2024$1.41$1.42+0.71%$1.45$1.3951,121 shs$26.41 million05/17/2024$1.40$1.40$1.44$1.3944,202 shs$26.04 million05/16/2024$1.42$1.40-1.41%$1.43$1.3915,707 shs$26.04 million05/15/2024$1.45$1.42-2.07%$1.48$1.3771,639 shs$26.41 million05/14/2024$1.47$1.45-1.36%$1.52$1.3766,597 shs$26.97 million05/13/2024$1.50$1.47-2.00%$1.55$1.4232,686 shs$27.34 million05/10/2024$1.52$1.50-1.32%$1.53$1.4340,709 shs$27.90 million05/09/2024$1.57$1.52-3.18%$1.57$1.5123,343 shs$28.27 million05/08/2024$1.57$1.57$1.62$1.5347,525 shs$29.20 million05/07/2024$1.57$1.57$1.63$1.5443,454 shs$29.20 million05/06/2024$1.62$1.57-3.09%$1.62$1.5368,778 shs$29.20 million05/03/2024$1.62$1.62$1.66$1.5245,802 shs$30.13 million05/02/2024$1.61$1.62+0.62%$1.76$1.53281,469 shs$30.08 million05/01/2024$1.67$1.61-3.59%$1.64$1.5175,057 shs$29.90 million04/30/2024$1.66$1.67+0.60%$1.70$1.60106,632 shs$31.01 million04/29/2024$1.44$1.66+15.28%$1.84$1.47474,649 shs$30.83 million04/26/2024$1.45$1.44-0.69%$1.49$1.4458,077 shs$26.74 million04/25/2024$1.50$1.45-3.33%$1.49$1.4452,572 shs$26.93 million04/24/2024$1.32$1.50+13.64%$1.53$1.33125,806 shs$27.86 million04/23/2024$1.27$1.32+3.94%$1.37$1.3048,007 shs$24.51 million04/22/2024$1.32$1.27-3.79%$1.30$1.2451,524 shs$23.58 million04/19/2024$1.40$1.32-5.71%$1.39$1.23108,601 shs$24.51 million04/18/2024$1.48$1.40-5.41%$1.52$1.3992,329 shs$26.00 million04/17/2024$1.45$1.48+2.07%$1.56$1.40388,666 shs$27.48 million04/16/2024$1.30$1.45+11.54%$1.46$1.32405,672 shs$26.92 million04/15/2024$1.58$1.30-17.72%$1.52$1.15841,211 shs$24.14 million04/12/2024$1.83$1.58-13.66%$1.93$1.331.02 million shs$29.34 million04/11/2024$3.98$1.83-54.02%$2.24$1.652.79 million shs$33.98 million04/10/2024$4.08$3.98-2.45%$4.19$3.9287,758 shs$73.91 million04/09/2024$4.10$4.08-0.49%$4.21$4.02127,386 shs$75.77 million04/08/2024$4.00$4.10+2.50%$4.20$3.83124,344 shs$76.14 millionMust-See: Elon’s New Invention is Absolutely Insane (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story…04/05/2024$3.76$4.00+6.38%$4.04$3.54122,866 shs$74.28 million04/04/2024$4.31$3.76-12.76%$4.43$3.74265,122 shs$69.82 million04/03/2024$4.04$4.31+6.68%$4.59$4.00191,707 shs$80.04 million04/02/2024$4.00$4.04+1.00%$4.17$3.79142,863 shs$75.02 million04/01/2024$3.79$4.00+5.54%$4.17$3.75125,141 shs$74.28 million03/29/2024$3.79$3.79$3.98$3.70126,662 shs$70.38 million03/28/2024$3.86$3.79-1.81%$3.98$3.70126,660 shs$70.38 million03/27/2024$3.91$3.86-1.28%$3.94$3.7058,893 shs$71.68 million03/26/2024$4.11$3.91-4.87%$4.18$3.80127,360 shs$72.61 million03/25/2024$3.68$4.11+11.68%$4.15$3.82157,234 shs$76.32 million03/22/2024$3.59$3.68+2.51%$3.85$3.5972,792 shs$68.34 million03/21/2024$4.02$3.59-10.70%$3.96$3.37148,048 shs$66.67 million03/20/2024$4.07$4.02-1.23%$4.05$3.8730,029 shs$74.65 million03/19/2024$4.18$4.07-2.63%$4.24$4.0238,684 shs$75.58 million03/18/2024$4.11$4.18+1.70%$4.27$3.9590,961 shs$77.62 million03/15/2024$4.12$4.11-0.24%$4.20$4.0516,308 shs$76.32 million03/14/2024$4.30$4.12-4.19%$4.30$3.81129,929 shs$76.51 million03/13/2024$4.17$4.30+3.12%$4.35$4.1795,925 shs$79.85 million03/12/2024$3.70$4.17+12.70%$4.37$3.73207,167 shs$77.42 million03/11/2024$3.95$3.70-6.33%$4.24$3.58160,259 shs$68.71 million03/08/2024$3.27$3.95+20.80%$4.32$3.43254,654 shs$73.35 million03/07/2024$3.36$3.27-2.68%$3.43$3.2561,393 shs$60.72 million03/06/2024$3.24$3.36+3.70%$3.43$3.2041,908 shs$62.40 million03/05/2024$3.42$3.24-5.26%$3.40$3.1630,101 shs$60.17 million03/04/2024$3.21$3.42+6.54%$3.47$3.1980,132 shs$63.51 million Related Companies: ORGS Stock Chart CLSD Stock Chart CNTB Stock Chart PRPH Stock Chart LFVN Stock Chart ASRT Stock Chart ORMP Stock Chart YS Stock Chart RLMD Stock Chart ETON Stock Chart Receive ENLV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enlivex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ENLV) was last updated on 6/3/2024 by MarketBeat.com Staff From Our PartnersAlert: Your Bank is Dying – Act Now or Lose Everything!Priority GoldDoes this make you sick?Allegiance GoldThe Only Energy Play You Should Be Looking AtWealthpin ProShocking $16T Elon Musk Crypto LeakCrypto 101 MediaNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsBiden replacement revealed?Paradigm PressHistoric Crash Could Wipe Away Your 401k (Govt Debt Explosion)Birch Gold[Webinar] Understanding Covered CallsOIC Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enlivex Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.